Biocept Inc (BIOC) - Financial and Strategic SWOT Analysis Review

  • ID: 4284958
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4
Summary

Biocept Inc (Biocept) is a developer of diagnostic solutions. The company provides biopharmaceutical and clinical research, and molecular oncology laboratory services. It provides tests for various solid tumor cancers. Biocept offers related instrumentation, OncoCEE technology, and analytical capabilities for rare event detection and genetic characterization. The company’s OncoCEE platform modifies rare cell capture and analyses methods. It offers patented methodology to isolate rare cells including circulating tumor cells, and cell-free circulating tumor DNA from the blood. The company also develops methodology to isolate cancer material including circulating tumor cells, and cell-free circulating tumor DNA. It serves medical and surgical oncologists, pathologists, hospitals, cancer centers, universities, and pharmaceutical and clinical researchers. Biocept is headquartered in San Diego, California, the US.

Biocept Inc Key Recent Developments

Feb 05, 2018: Biocept Receives Additional Patent Issuances in Three Major International Territories for its Target Selector Platform
Jan 30, 2018: Biocept Comments on Updated Consensus Medical Guidelines Recommending Liquid Biopsy for Profiling of Tumor Biomarkers to Assist with the Treatment of Patients with Lung Cancer
Jan 04, 2018: Biocept Obtains Patent in Australia for its Molecular Biomarker Technology For the Detection of Cancer-Associated Mutations in Blood, Tissue, and Other Biological Sources
Dec 18, 2017: Biocept Signs In-Network Provider Agreement with Wellmark Blue Cross Blue Shield Expanding Coverage for its Target Selector Platform in Iowa and South Dakota
Dec 05, 2017: First U.S. Patent Issued for Biocept's Target Selector Oncogene Mutation Enrichment and Detection Liquid Biopsy ctDNA Platform

This comprehensive SWOT profile of Biocept Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Biocept Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Biocept Inc - Key Information
  • Biocept Inc - Overview
  • Biocept Inc - Key Employees
  • Biocept Inc - Key Employee Biographies
  • Biocept Inc - Key Operational Heads
  • Biocept Inc - Major Products and Services
  • Biocept Inc - History
  • Biocept Inc - Company Statement
  • Biocept Inc - Locations And Subsidiaries
  • Biocept Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Biocept Inc - Business Description
  • Biocept Inc - Corporate Strategy
  • Biocept Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Biocept Inc - Strengths
  • Biocept Inc - Weaknesses
  • Biocept Inc - Opportunities
  • Biocept Inc - Threats
  • Biocept Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Biocept Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Biocept Inc, Key Information
  • Biocept Inc, Key Ratios
  • Biocept Inc, Share Data
  • Biocept Inc, Major Products and Services
  • Biocept Inc, History
  • Biocept Inc, Key Employees
  • Biocept Inc, Key Employee Biographies
  • Biocept Inc, Key Operational Heads
  • Biocept Inc, Other Locations
  • Biocept Inc, Subsidiaries
  • Biocept Inc, Key Manufacturing facilities
  • Biocept Inc, Key Competitors
  • Biocept Inc, SWOT Analysis
  • Biocept Inc, Ratios based on current share price
  • Biocept Inc, Annual Ratios
  • Biocept Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Biocept Inc, Performance Chart
  • Biocept Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll